Correction: Beyond axillary lymph node metastasis, BMI and menopausal status are prognostic determinants for triple-negative breast cancer treated by neoadjuvant chemotherapy

0Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

Dr. Anne-Sophie Hamy should be included in the byline as the sixth author. Her affiliations are 6: Residual Tumor and Response to Treatment Lab, Translational Research Department, Institut Curie, Paris, France, and 7: UMR932 Immunity and Cancer, INSERM, Paris, France. The contributions of this author are as follows: Wrote the manuscript. The correct citation is: Bonsang-Kitzis H, Chaltier L, Belin L, Savignoni A, Rouzier R, Hamy AS, et al. (2015) Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy. PLoS ONE 10(12): e0144359. doi:10.1371/journal.pone.0144359.

Cite

CITATION STYLE

APA

Bonsang-Kitzis, H., Chaltier, L., Belin, L., Savignoni, A., Rouzier, R., Hamy, A. S., … Reyal, F. (2016, July 1). Correction: Beyond axillary lymph node metastasis, BMI and menopausal status are prognostic determinants for triple-negative breast cancer treated by neoadjuvant chemotherapy. PLoS ONE. Public Library of Science. https://doi.org/10.1371/journal.pone.0159123

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free